Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Bennett

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
Heart Rhythm|July 6, 2024
Safety of ward-based, non-physician-led, cardiac monitor implantationWilliam T C Procter, Jonathan Bennett, James Elliott, et al.
Journal of Medicinal Chemistry|April 19, 2002
Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationshipsJulia M Adam, D Jonathan Bennett, Anton Bom, et al.
The Journal of Pediatrics|February 26, 2014
Effect of Hispanic ethnicity and language barriers on appendiceal perforation rates and imaging in childrenMichael N Levas, Peter S Dayan, Manoj K Mittal, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically importantJiaqiang Cai, Xavier Fradera, Mario van Zeeland, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 17, 2026
Extracellular volume fraction associates with long-term outcome in patients with severe symptomatic aortic stenosis: 10-year outcomes of the RELIEF-AS StudyNikoo Aziminia, George D Thornton, Jonathan Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2021
Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffoldWensheng Yu, Yongqi Deng, David Sloman, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2011
1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pkaWullie Arbuckle, Mark Baugh, Simone Belshaw, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2014
Design of prodrugs to enhance colonic absorption by increasing lipophilicity and blocking ionizationRebecca Nofsinger, Sophie-Dorothee Clas, Rosa I Sanchez, et al.
Cerebrovascular Diseases Extra|January 16, 2023
Evaluation of Microvascular Rarefaction in Vascular Cognitive Impairment and Heart Failure (CRUCIAL): Study Protocol for an Observational StudyMaud van Dinther, Jonathan Bennett, George D Thornton, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2016
Imidazopyridyl compounds as aldosterone synthase inhibitorsBrent R Whitehead, Michael M-C Lo, Amjad Ali, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Heart Rhythm|July 6, 2024
Safety of ward-based, non-physician-led, cardiac monitor implantationWilliam T C Procter, Jonathan Bennett, James Elliott, et al.
Journal of Medicinal Chemistry|April 19, 2002
Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationshipsJulia M Adam, D Jonathan Bennett, Anton Bom, et al.
The Journal of Pediatrics|February 26, 2014
Effect of Hispanic ethnicity and language barriers on appendiceal perforation rates and imaging in childrenMichael N Levas, Peter S Dayan, Manoj K Mittal, et al.
Bioorganic & Medicinal Chemistry Letters|June 29, 2010
4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is critically importantJiaqiang Cai, Xavier Fradera, Mario van Zeeland, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 17, 2026
Extracellular volume fraction associates with long-term outcome in patients with severe symptomatic aortic stenosis: 10-year outcomes of the RELIEF-AS StudyNikoo Aziminia, George D Thornton, Jonathan Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|August 15, 2021
Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffoldWensheng Yu, Yongqi Deng, David Sloman, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2011
1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pkaWullie Arbuckle, Mark Baugh, Simone Belshaw, et al.
Pharmaceuticals (Basel, Switzerland)|February 26, 2014
Design of prodrugs to enhance colonic absorption by increasing lipophilicity and blocking ionizationRebecca Nofsinger, Sophie-Dorothee Clas, Rosa I Sanchez, et al.
Cerebrovascular Diseases Extra|January 16, 2023
Evaluation of Microvascular Rarefaction in Vascular Cognitive Impairment and Heart Failure (CRUCIAL): Study Protocol for an Observational StudyMaud van Dinther, Jonathan Bennett, George D Thornton, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2016
Imidazopyridyl compounds as aldosterone synthase inhibitorsBrent R Whitehead, Michael M-C Lo, Amjad Ali, et al.
Pageof 11